190 related articles for article (PubMed ID: 17361206)
1. Loss of membranous Ep-CAM in budding colorectal carcinoma cells.
Gosens MJ; van Kempen LC; van de Velde CJ; van Krieken JH; Nagtegaal ID
Mod Pathol; 2007 Feb; 20(2):221-32. PubMed ID: 17361206
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of epithelial cell adhesion molecule in primary, metastatic, and recurrent/chemotherapy-resistant epithelial ovarian cancer: implications for epithelial cell adhesion molecule-specific immunotherapy.
Bellone S; Siegel ER; Cocco E; Cargnelutti M; Silasi DA; Azodi M; Schwartz PE; Rutherford TJ; Pecorelli S; Santin AD
Int J Gynecol Cancer; 2009 Jul; 19(5):860-6. PubMed ID: 19574774
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of Ep-CAM AND Her-2/neu overexpression in invasive breast cancer.
Spizzo G; Obrist P; Ensinger C; Theurl I; Dünser M; Ramoni A; Gunsilius E; Eibl G; Mikuz G; Gastl G
Int J Cancer; 2002 Apr; 98(6):883-8. PubMed ID: 11948467
[TBL] [Abstract][Full Text] [Related]
4. EpCAM nuclear localization identifies aggressive thyroid cancer and is a marker for poor prognosis.
Ralhan R; Cao J; Lim T; Macmillan C; Freeman JL; Walfish PG
BMC Cancer; 2010 Jun; 10():331. PubMed ID: 20579375
[TBL] [Abstract][Full Text] [Related]
5. The structural analysis of adhesions mediated by Ep-CAM.
Balzar M; Prins FA; Bakker HA; Fleuren GJ; Warnaar SO; Litvinov SV
Exp Cell Res; 1999 Jan; 246(1):108-21. PubMed ID: 9882520
[TBL] [Abstract][Full Text] [Related]
6. Epithelial-mesenchymal transition (EMT) protein expression in a cohort of stage II colorectal cancer patients with characterized tumor budding and mismatch repair protein status.
Kevans D; Wang LM; Sheahan K; Hyland J; O'Donoghue D; Mulcahy H; O'Sullivan J
Int J Surg Pathol; 2011 Dec; 19(6):751-60. PubMed ID: 21791486
[TBL] [Abstract][Full Text] [Related]
7. Cytoplasmic Trop-1/Ep-CAM overexpression is associated with a favorable outcome in node-positive breast cancer.
Alberti S; Ambrogi F; Boracchi P; Fornili M; Querzoli P; Pedriali M; La Sorda R; Lattanzio R; Tripaldi R; Piantelli M; Biganzoli E; Coradini D
Jpn J Clin Oncol; 2012 Dec; 42(12):1128-37. PubMed ID: 23072840
[TBL] [Abstract][Full Text] [Related]
8. An Ep-ICD based index is a marker of aggressiveness and poor prognosis in thyroid carcinoma.
He HC; Kashat L; Kak I; Kunavisarut T; Gundelach R; Kim D; So AK; MacMillan C; Freeman JL; Ralhan R; Walfish PG
PLoS One; 2012; 7(9):e42893. PubMed ID: 23049733
[TBL] [Abstract][Full Text] [Related]
9. DNA methylation and histone modification regulate silencing of epithelial cell adhesion molecule for tumor invasion and progression.
Tai KY; Shiah SG; Shieh YS; Kao YR; Chi CY; Huang E; Lee HS; Chang LC; Yang PC; Wu CW
Oncogene; 2007 Jun; 26(27):3989-97. PubMed ID: 17213811
[TBL] [Abstract][Full Text] [Related]
10. KSA antigen Ep-CAM mediates cell-cell adhesion of pancreatic epithelial cells: morphoregulatory roles in pancreatic islet development.
Cirulli V; Crisa L; Beattie GM; Mally MI; Lopez AD; Fannon A; Ptasznik A; Inverardi L; Ricordi C; Deerinck T; Ellisman M; Reisfeld RA; Hayek A
J Cell Biol; 1998 Mar; 140(6):1519-34. PubMed ID: 9508783
[TBL] [Abstract][Full Text] [Related]
11. Possible contribution of CD44 variant 6 and nuclear beta-catenin expression to the formation of budding tumor cells in patients with T1 colorectal carcinoma.
Masaki T; Goto A; Sugiyama M; Matsuoka H; Abe N; Sakamoto A; Atomi Y
Cancer; 2001 Nov; 92(10):2539-46. PubMed ID: 11745187
[TBL] [Abstract][Full Text] [Related]
12. Histopathologic features of the tumor budding in adenocarcinoma of the lung: tumor budding as an index to predict the potential aggressiveness.
Yamaguchi Y; Ishii G; Kojima M; Yoh K; Otsuka H; Otaki Y; Aokage K; Yanagi S; Nagai K; Nishiwaki Y; Ochiai A
J Thorac Oncol; 2010 Sep; 5(9):1361-8. PubMed ID: 20631633
[TBL] [Abstract][Full Text] [Related]
13. Budding invasive margin and prognosis in colorectal cancer--no direct association with beta-catenin expression.
Hörkkö TT; Klintrup K; Mäkinen JM; Näpänkangas JB; Tuominen HJ; Mäkelä J; Karttunen TJ; Mäkinen MJ
Eur J Cancer; 2006 May; 42(7):964-71. PubMed ID: 16563744
[TBL] [Abstract][Full Text] [Related]
14. The expression of Ep-CAM (17-1A) in squamous cell cancers of the lung.
Piyathilake CJ; Frost AR; Weiss H; Manne U; Heimburger DC; Grizzle WE
Hum Pathol; 2000 Apr; 31(4):482-7. PubMed ID: 10821496
[TBL] [Abstract][Full Text] [Related]
15. Ep-CAM expression in pancreatic and ampullary carcinomas: frequency and prognostic relevance.
Fong D; Steurer M; Obrist P; Barbieri V; Margreiter R; Amberger A; Laimer K; Gastl G; Tzankov A; Spizzo G
J Clin Pathol; 2008 Jan; 61(1):31-5. PubMed ID: 16775119
[TBL] [Abstract][Full Text] [Related]
16. Epithelial cell adhesion molecule (Ep-CAM) modulates cell-cell interactions mediated by classic cadherins.
Litvinov SV; Balzar M; Winter MJ; Bakker HA; Briaire-de Bruijn IH; Prins F; Fleuren GJ; Warnaar SO
J Cell Biol; 1997 Dec; 139(5):1337-48. PubMed ID: 9382878
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical analysis based Ep-ICD subcellular localization index (ESLI) is a novel marker for metastatic papillary thyroid microcarcinoma.
Kunavisarut T; Kak I; Macmillan C; Ralhan R; Walfish PG
BMC Cancer; 2012 Nov; 12():523. PubMed ID: 23153310
[TBL] [Abstract][Full Text] [Related]
18. Is Ep-CAM Expression a Diagnostic and Prognostic Biomarker for Colorectal Cancer? A Systematic Meta-Analysis.
Han S; Zong S; Shi Q; Li H; Liu S; Yang W; Li W; Hou F
EBioMedicine; 2017 Jun; 20():61-69. PubMed ID: 28558958
[TBL] [Abstract][Full Text] [Related]
19. Adenocarcinoma cells exposed in vitro to Navelbine or Taxol increase Ep-CAM expression through a novel mechanism.
Thurmond LM; Stimmel JB; Ingram AC; Ryan CH; Murray DM; Eberwein DJ; Witherspoon SM; Knick VC
Cancer Immunol Immunother; 2003 Jul; 52(7):429-37. PubMed ID: 12695858
[TBL] [Abstract][Full Text] [Related]
20. Ep-CAM expression in squamous cell carcinoma of the esophagus: a potential therapeutic target and prognostic marker.
Stoecklein NH; Siegmund A; Scheunemann P; Luebke AM; Erbersdobler A; Verde PE; Eisenberger CF; Peiper M; Rehders A; Esch JS; Knoefel WT; Hosch SB
BMC Cancer; 2006 Jun; 6():165. PubMed ID: 16796747
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
